New drug trial aims to lift the fog of bipolar depression

NCT ID NCT06696755

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a new drug called Icalcaprant can help control depressive episodes in adults with bipolar I or II disorder. About 195 participants will take either the drug or a placebo pill daily for six weeks, while continuing their current mood stabilizer medication. Researchers will measure changes in depression symptoms and monitor safety to see if the drug is effective and well-tolerated.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Accel Research Sites Network - St. Pete /ID# 272962
RECRUITING

Largo, Florida, 33777, United States
Advanced Research Center /ID# 272828
RECRUITING

Anaheim, California, 92805, United States
Amr Conventions Research /ID# 272867
RECRUITING

Warrenville, Illinois, 60555, United States
Apg Research /ID# 272925
RECRUITING

Orlando, Florida, 32803, United States
Catalina Research Institute, LLC /ID# 272831
RECRUITING

Montclair, California, 91763, United States
CenExcel Clinical Research - Main Facility /ID# 273101
RECRUITING

Hollywood, Florida, 33024, United States
Clinical Research Center Of Florida /ID# 278790
RECRUITING

Pompano Beach, Florida, 33060, United States
Collaborative Neuroscience Research - Garden Grove /ID# 271917
RECRUITING

Garden Grove, California, 92845, United States
Combined Research Orlando Phase I-IV /ID# 279458
RECRUITING

Orlando, Florida, 32814, United States
Community Clinical Research - Austin - Cross Park Drive /ID# 272940
RECRUITING

Austin, Texas, 78754, United States
Core Clinical Research /ID# 272955
RECRUITING

Everett, Washington, 98201, United States
Elixia - Houston /ID# 279200
RECRUITING

Houston, Texas, 77007, United States
Excell Research /ID# 272854
RECRUITING

Oceanside, California, 92056, United States
Georgia Psychiatric Consultants & Advanced Discovery Research /ID# 279438
RECRUITING

Atlanta, Georgia, 30318, United States
Manhattan Behavioral Medicine /ID# 279769
RECRUITING

New York, New York, 10036, United States
Neuroscience Institute - West Palm Beach /ID# 272922
RECRUITING

West Palm Beach, Florida, 33407, United States
Northwest Clinical Research Center /ID# 272847
RECRUITING

Bellevue, Washington, 98007, United States
Pacific Neuropsychiatric Specialists - Orange /ID# 273118
RECRUITING

Orange, California, 92868, United States
Pillar Clinical Research - Chicago /ID# 272823
RECRUITING

Chicago, Illinois, 60641, United States

Contact Phone: •••-•••-••••
Pillar Clinical Research - Richardson /ID# 272821
RECRUITING

Richardson, Texas, 75080, United States
Sanro Clinical Research Group /ID# 279462
RECRUITING

Bryant, Arkansas, 72022, United States
Schuster Medical Research Institute /ID# 272848
RECRUITING

Sherman Oaks, California, 91403, United States
Sooner Clinical Research /ID# 272856
RECRUITING

Oklahoma City, Oklahoma, 73116, United States
The Ohio State University /ID# 272954
RECRUITING

Columbus, Ohio, 43210, United States
University Of Cincinnati Medical Center /ID# 274160
RECRUITING

Cincinnati, Ohio, 45219, United States

Conditions

Explore the condition pages connected to this study.

BIPOLAR I DISORDER BIPOLAR II DISORDER